ZBH

#679
Zimmer Biomet Holdings, Inc. Common Stock
82.1 8 USD
-0.89%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
82.00
82.65
Rango anual
0.83
103.69
Cambio diario
-0.89%
Variación mensual
+1.70%
Variación en los últimos 6 meses
-15.47%
Cambio anual
-20.60%
Cierres anteriores
82.9 2
Open
82.6 5
Mínimo
82.0 0
High
82.6 5
Volumen
195
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 15.9 B
  • Employee 17 K
  • Founded N/A
  • CEO Ivan Tornos
  • Website www.zimmerbiomet.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKPL53
  • Industry Aparatos médicos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
25.33
Relación precio/flujo de caja
2.25
Dividendos por acción
0.96
Rendimiento por dividendo, %
1.07

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.

Noticias